Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
506.00
-14.00 (-2.69%)
At close: Apr 20, 2026

HKG:6990 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
117,99291,45637,11322,555--
Market Cap Growth
103.60%146.43%64.54%---
Enterprise Value
113,11486,65334,05420,931--
Last Close Price
506.00392.20163.30102.90--
PS Ratio
51.5239.9418.0413.29--
PB Ratio
21.7916.8910.548.79--
P/TBV Ratio
21.7916.8910.558.79--
P/OCF Ratio
---343.75--
EV/Sales Ratio
49.3937.8416.5512.33--
Debt / Equity Ratio
0.020.020.040.03-0.93-0.90
Net Debt / Equity Ratio
-0.90-0.90-0.89-1.04-0.91-0.87
Net Debt / EBITDA Ratio
12.0212.0212.745.79-7.94-2.98
Net Debt / FCF Ratio
14.3314.335.80113.36-9.59-3.98
Asset Turnover
0.400.400.500.680.89-
Inventory Turnover
3.303.307.6013.515.36-
Quick Ratio
4.744.744.092.350.050.04
Current Ratio
5.135.134.312.530.080.09
Return on Equity (ROE)
-9.34%-9.34%-9.46%---
Return on Assets (ROA)
-5.11%-5.11%-4.49%-12.60%-27.27%-
Return on Capital Employed (ROCE)
-8.40%-8.40%-8.10%-18.90%12.40%30.20%
Earnings Yield
-0.36%-0.46%-0.77%-2.80%--
FCF Yield
-0.29%-0.37%-1.45%-0.10%--
Buyback Yield / Dilution
-4.01%-4.01%-20.70%-92.24%-3.31%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.